Brande Victorian, Managing Editor of MadameNoire, discusses the 60th Annual Grammy Awards. R&B star Bruno Mars took home six awards including Album of the Year, upsetting frontrunners Kendrick Lamar and Jay-Z.
We talk about the shortage of female nominees in most of the major categories and what can be done to change that. Victorian digs into Kesha's powerful speech and Janelle Monae's poignant message.
We also talk about the most popular memes from the night, such as Blue Ivy trying to quiet her parents down and Rihanna and Kendrick Lamar's win for Best Rap/Sung Duo.
Kim Kardashian’s shapewear brand Skims has doubled its valuation to $3.2 billion. Investors have taken a bet on the success of this brand in the form of fresh funds for the two-year-old company.
McDonald's missed on both the top and bottom lines in its Q4 earnings, marking the fourth loss for the fast-food giant in the past eight quarters. It comes as higher costs from food to wages ate into the blue-chip company's profits. George Seay, CEO of investment advisor Annandale Capital, joined Wake Up with Cheddar to discuss the recent numbers and the better-than-expected success of the McPlant burger made with plant-based Beyond Meat. "They're changing with the times, and they have to," Seay noted. "You can just sell a Big Mac to everybody. There's a lot of people who don't want to eat a Big Mac anymore."
Moderna launched a clinical trial of a COVID-19 booster shot specifically targeting the omicron variant. The first participant has already received a dose, and Moderna expects to enroll about 600 adults total, split between two groups. In the first group, participants will have previously received two doses of the Moderna vaccine, and in the second, participants will have received its booster. Dr. Paul Burton, chief medical officer at Moderna, joined Cheddar’s Opening Bell to discuss the trial, yearly boosters, and what lies ahead for the company.
